Point72 (Difc) LTD Vera Therapeutics, Inc. Transaction History
Point72 (Difc) LTD
- $2.95 Trillion
- Q3 2024
A detailed history of Point72 (Difc) LTD transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 43,789 shares of VERA stock, worth $1.85 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
43,789
Previous 40,413
8.35%
Holding current value
$1.85 Million
Previous $1.46 Billion
32.37%
% of portfolio
0.07%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.2MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$182 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$167 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$141 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$125 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$118 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.14B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...